Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome

Archive ouverte

Billon, Clarisse | Adham, Salma | Hernandez Poblete, Natalia | Legrand, Anne | Frank, Michael | Chiche, Laurent | Zuily, Stephane | Benistan, Karelle | Savale, Laurent | Zaafrane-Khachnaoui, Khaoula | Brehin, Anne-Claire | Bal, Laurence | Busa, Tiffany | Fradin, Mélanie | Quelin, Chloé | Chesneau, Bertrand | Wahl, Denis | Fergelot, Patricia | Goizet, Cyril | Mirault, Tristan | Jeunemaitre, Xavier | Albuisson, Juliette

Edité par CCSD ; BioMed Central -

International audience. Abstract Background FLNA Loss-of-Function (LoF) causes periventricular nodular heterotopia type 1 (PVNH1), an acknowledged cause of seizures of various types. Neurological symptoms are inconstant, and cardiovascular (CV) defects or connective tissue disorders (CTD) have regularly been associated. We aimed at refining the description of CV and CTD features in patients with FLNA LoF and depicting the multisystemic nature of this condition. Methods We retrospectively evaluated FLNA variants and clinical presentations in FLNA LoF patient with at least one CV or CTD feature, from three cohorts: ten patients from the French Reference Center for Rare Vascular Diseases, 23 patients from the national reference diagnostic lab for filaminopathies-A, and 59 patients from literature review. Results Half of patients did not present neurological symptoms. Most patients presented a syndromic association combining CV and CTD features. CV anomalies, mostly aortic aneurysm and/or dilation were present in 75% of patients. CTD features were present in 75%. Variants analysis demonstrated an enrichment of coding variants in the CH1 domain of FLNA protein. Conclusion In FLNA LoF patients, the absence of seizures should not be overlooked. When considering a diagnosis of PVNH1, the assessment for CV and CTD anomalies is of major interest as they represent interlinked features. We recommend systematic study of FLNA within CTD genes panels, regardless of the presence of neurological symptoms.

Suggestions

Du même auteur

PFMG2025–integrating genomic medicine into the national healthcare system in France

Archive ouverte | Abadie, Caroline | CCSD

International audience. Integrating genomic medicine into healthcare systems is a health policy challenge that requires continuously transferring scientific advances into clinics and ensuring equal access for patien...

Periodontal (formerly type VIII ) Ehlers–Danlos syndrome: Description of 13 novel cases and expansion of the clinical phenotype

Archive ouverte | El Chehadeh, Salima | CCSD

International audience

Clinical utility gene card: for pseudoxanthoma elasticum

Archive ouverte | Legrand, Anne | CCSD

International audience

Chargement des enrichissements...